Skip to main content

Closed

PTHS: Pelthos Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin-157.7%

ROIC-31.6%

Financially safe

Stretched

Debt / equity1.51×

Interest coverage-8.4×

Current ratio2.76×

Pelthos Therapeutics Inc.

PTHSNew York Stock Exchange Arca·USD·Closed

Pelthos Therapeutics Inc.

PTHSNew York Stock Exchange Arca·USD·Closed

$26.70

−0.52%

$26.70

−$0.14 (0.52%)

52W Range

49thpctl

Volume

4.31×avg

Mkt Cap

17.31MUSD

P/E

-0.7TTM

Div Yield

–ann

52W Range

49thpctl

Volume

4.31×avg

Market Cap

17.31MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings